Randomized controlled trial of ovarian function suppression plus tamoxifen versus the same endocrine therapy plus chemotherapy: Is chemotherapy necessary for premenopausal women with node-positive, endocrine-responsive breast cancer? First results of International Breast Cancer Study Group Trial 11-93
B. Thürlimann, K. N. Price, M. Castiglione, A. S. Coates, A. Goldhirsch, R. D. Gelber, J. Forbes, S. Holmberg, A. Veronesi, J. Bernhard, D. Zahrich
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Randomized controlled trial of ovarian function suppression plus tamoxifen versus the same endocrine therapy plus chemotherapy: Is chemotherapy necessary for premenopausal women with node-positive, endocrine-responsive breast cancer? First results of International Breast Cancer Study Group Trial 11-93'. Together they form a unique fingerprint.